水痘疫苗市場報告：趨勢、預測和競爭分析（至 2031 年）

由於醫院和診所市場存在機會，全球水痘疫苗市場的未來前景光明。預計到 2031 年全球水痘疫苗市場規模將達到 49 億美元，2025 年至 2031 年的複合年成長率為 5.8%。該市場的主要驅動力是全球疫苗接種計劃的增加、公眾對水痘疫苗使用意識的增強以及政府對疫苗接種計劃的資助增加。

• Lucintel 預測，在預測期內，帶狀皰疹將在所有應用中成長最高。
• 根據最終用途，預計醫院在預測期內將實現高速成長。
• 按地區分類，北美將繼續成為最大的地區，因為該地區已建立疫苗接種計劃，且人口不斷成長導致疫苗接種需求不斷成長。

水痘疫苗市場的策略性成長機會

水痘疫苗市場的成長得益於技術發展、認知的提高以及重點領域的疫苗宣傳活動的加強。

• 新市場：新市場為擴大水痘疫苗接種計畫提供了許多成長機會。透過提高這些地區的可用性和可負擔性，將為擴大市場佔有率和降低全球整體盛行率創造有利條件。
• 開發聯合疫苗：投資包括水痘在內的聯合疫苗將簡化免疫接種時間表並促進依從性。該策略可以透過鞏固免疫力和簡化疫苗接種流程來提高市場吸引力。
• 增強疫苗配方：開發副作用更少、免疫持續時間更長的新型、更好的疫苗配方具有成長機會。預計這些進展將提高水痘疫苗的接受度和接種率。
• 納入常規免疫計畫：將水痘疫苗接種納入兒童免疫計畫有助於維持兒童免疫接種覆蓋率並預防疫情爆發。這種方法將提高疫苗接種率並改善整體公共衛生狀況。
• 公共衛生意識提升計劃和教育：注重對公共衛生和水痘疫苗接種重要性的認知可能會促進成長。旨在向人們告知疫苗接種的風險和好處的教育計劃可以提高疫苗接種率和疫苗接種率。

這些機會正在透過改善獲取途徑、疫苗技術進步和擴大公共衛生領域的可能性來塑造水痘疫苗市場。

水痘疫苗市場促進因素與挑戰

水痘疫苗市場的參與者面臨各種影響、促進因素和挑戰，例如技術進步、經濟因素和法規。了解這些因素對於了解市場格局至關重要。

推動水痘疫苗市場發展的因素有：

• 技術進步：疫苗技術發生了重大變化，包括更新的配方和組合，從而促進了銷售。這些改進使得疫苗更有效率、更安全，從而提高了疫苗的接受率並改善了公眾健康。
• 提高公眾意識：公眾意識的提高導致水痘疫苗接種的需求增加。因此，公共衛生宣傳活動和教育干預提高了疫苗接種率並減少了水痘病例。
• 增加疫苗接種機會：市場成長的動力來自於服務不足的新興市場中水痘疫苗接種機會的增加。隨著可取得且價格合理的疫苗的出現，全球水痘發病率下降，疫苗接種率上升。

水痘疫苗市場面臨的挑戰是：

• 監管挑戰：滿足疫苗產品認證和安全的嚴格準則通常是一個障礙。遵守市場進入和產品開發所需的法規會影響時間表和費用。
• 經濟限制：經濟因素會影響市場動態，例如由於經濟狀況變化導致疫苗生產成本和可負擔性的波動。實現成本和品質之間的平衡對於有競爭力的業務擴張至關重要。

所有這些促進因素和挑戰都會影響產品開發、市場開發和法規遵循度，從而塑造水痘疫苗市場。

目錄

第1章執行摘要

第 2 章全球水痘疫苗市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業促進因素與挑戰

第 3 章 市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）與預測（2025-2031）
• 全球水痘疫苗市場趨勢（2019-2024）及預測（2025-2031）
• 全球水痘疫苗市場（依產品類型）
  • 單價水痘疫苗
  • 聯合水痘疫苗
• 全球水痘疫苗市場（按應用）
  • 腮腺炎
  • 麻疹
  • 德國麻疹
  • 水痘疫苗接種
  • 帶狀皰疹
  • 免疫
  • 水痘疫苗接種
• 全球水痘疫苗市場（依最終用途分類）
  • 醫院
  • 診所
  • 其他

第 4 章區域市場趨勢與預測分析（2019-2031 年）

• 全球水痘疫苗市場（按區域）
• 北美水痘疫苗市場
• 歐洲水痘疫苗市場
• 亞太水痘疫苗市場
• 世界其他地區的水痘疫苗市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球水痘疫苗市場成長機會（依產品類型）
  • 全球水痘疫苗市場的成長機會（按應用）
  • 全球水痘疫苗市場成長機會（依最終用途分類）
  • 全球水痘疫苗市場成長機會（按地區）
• 全球水痘疫苗市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球水痘疫苗市場產能擴大
  • 全球水痘疫苗市場的企業合併
  • 認證和許可

第7章主要企業簡介

• Bio-Med
• GlaxoSmithKline
• Emcure Pharmaceuticals
• Novo Medi Services
• Sanofi
• Takeda Pharmaceutical
• Changchun BCHT Biotechnology
• Green Cross Holdings
• Merck
• Mitsubishi Chemical Holdings

The future of the global chickenpox vaccine market looks promising with opportunities in the hospital and clinic markets. The global chickenpox vaccine market is expected to reach an estimated $4.9 billion by 2031 with a CAGR of 5.8% from 2025 to 2031. The major drivers for this market are the increasing number of vaccination programs worldwide, the rising public awareness of the use of chickenpox vaccines, and the growing government contribution to immunization programs.

• Lucintel forecasts that, within the application category, herpes zoster is expected to witness the highest growth over the forecast period.
• Within the end-use category, the hospital is expected to witness higher growth over the forecast period.
• In terms of regions, North America will remain the largest region due to the presence of a well-established vaccination program and the growing demand for vaccine coverage with an expanding population in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Chickenpox Vaccine Market

The market for chickenpox vaccines is witnessing multiple emerging trends that are shaping future vaccination efforts and public health strategies.

• More Emphasis on Combination Vaccines: There is growing interest in combination vaccines that include chickenpox along with other vaccines. This simplification of vaccination schedules and the greater likelihood of adherence will increase overall immunization rates.
• Access to Emerging Markets: Global coverage has increased due to efforts to extend vaccination programs to emerging markets. Better accessibility and affordability have led to higher rates of immunization and fewer cases of chickenpox in previously underserved areas.
• Better Vaccine Formulations: Improvements in vaccine formulations are resulting in more effective vaccines with longer-lasting immunity and fewer side effects. It is expected that these improvements will enhance the performance and safety of vaccines, thus increasing their acceptance and use by a wider population.
• Incorporation into Routine Immunization Schedules: Several countries are incorporating chickenpox vaccination into routine immunization schedules. The intention behind this trend is to ensure uniformity across the board, reducing cases of chickenpox that could lead to outbreaks.
• Emphasis on Public Health Campaigns: Public health campaigns have shifted their focus toward creating awareness about the need for chickenpox vaccination. These campaigns contribute to enlightening people, addressing vaccine hesitancy, and increasing vaccination levels.

These trends are revamping the chickenpox vaccine market through improved vaccine technology, broader access, and heightened public awareness.

Recent Developments in the Chickenpox Vaccine Market

The chickenpox vaccine market is witnessing several key developments that reflect advancements in vaccine technology, increased access, and improved public health initiatives.

• Introduction of Combination Vaccines: New combination vaccines that include chickenpox alongside other childhood vaccines are being introduced. The creation of these new combination vaccines will streamline vaccination schedules, improve compliance rates, and enhance overall vaccination coverage.
• Expansion of Vaccine Access: Initiatives are underway to increase chickenpox vaccine accessibility in underserved and rural areas. This move results from governmental measures and public health campaigns aimed at enhancing immunization coverage while minimizing outbreaks.
• Advancements in Vaccine Formulations: Recent advances in vaccine formulations result in better vaccines with greater efficacy, prolonged protection, and fewer side effects. These enhancements also contribute to improved vaccine performance and increased acceptability.
• Enhanced Public Health Campaigns: Public health campaigns are on the rise that focus on sensitizing the general population about the importance of chickenpox vaccination. Awareness programs like this help educate people, combat hesitancy about vaccinations by providing information, and boost vaccination rates.
• Integration into Routine Immunization: Several countries are incorporating chickenpox vaccination into their routine immunization schedules. The aim is to ensure universal coverage, thus reducing cases of chickenpox and preventing outbreaks.

These developments are advancing the chickenpox vaccine market by improving vaccine technology, increasing access, and enhancing public health efforts.

Strategic Growth Opportunities for Chickenpox Vaccine Market

Accelerating the growth of the chickenpox vaccine market is the development of technology, growing awareness, and increased immunization campaigns in key sectors.

• New Markets: New markets offer plenty of opportunities for growth in expanding chickenpox vaccination programs. Creating favorable conditions for a larger market share and a decrease in overall global cases will be achieved through improvements in accessibility and affordability in these regions.
• Combined Vaccine Development: Investing in combination vaccines that include varicella will simplify immunization schedules and foster compliance. This strategy can improve marketing appeal by consolidating immunities and simplifying the vaccination process.
• Enhanced Vaccine Formulation: Growth opportunities exist in developing better and new formulations with fewer side effects and longer immunity periods for vaccines. It is expected that such developments will promote acceptance and thus increase the use of chickenpox vaccines.
• Embedding Into Routine Immunization Schedules: By integrating chickenpox vaccination into planned childhood immunizations, children's coverage can be maintained, thereby averting outbreaks. This method can lead to higher rates of vaccination and better overall public health.
• Public Health Awareness Programs and Education: Focusing on public health and awareness about the importance of chickenpox vaccination has the potential to drive growth. Education programs aimed at informing people about the risks and benefits of immunizations will lead to increased uptake and coverage for vaccines.

These opportunities have shaped the chickenpox vaccine market by increasing its reach through access improvements, technological advances in vaccines, and expansion of possibilities within public health areas.

Chickenpox Vaccine Market Driver and Challenges

Players in the chickenpox vaccine market are subject to various influences, drivers, and challenges such as technological advancements, economic factors, and regulations. Understanding these elements is vital for navigating the market landscape.

The factors driving the chickenpox vaccine market include:

• Technological Advancements: Vaccination technologies have undergone significant changes, such as newer formulas and combinations, which have boosted sales. These improvements heighten vaccine efficiency and safety, leading to higher acceptance rates and better public health outcomes.
• Increased Public Awareness: There is an increasing demand for chickenpox vaccinations due to heightened awareness among the public. This has resulted in increased vaccination rates through public health campaigns and educational interventions that have reduced cases of chickenpox.
• Expansion of Vaccine Access: The market's growth has been driven by attempts to expand access to chickenpox vaccines in underserved and emerging markets. Improved availability and affordability have led to a decline in the global incidence of chickenpox and enhanced immunization coverage.

Challenges in the chickenpox vaccine market include:

• Regulatory Challenges: Issues arising from meeting strict guidelines governing accreditation for vaccine products and safety often pose obstacles. Compliance with rules needed for market entry or product development affects timelines and expenditures.
• Economic Constraints: Economic factors can influence market dynamics, such as fluctuating vaccine production costs and affordability due to changing economic conditions. Maintaining a cost-quality balance is important for competitive business expansion.

All these drivers and challenges shape the chickenpox vaccine market because they affect product development, market growth, and regulatory compliance.

List of Chickenpox Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chickenpox vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chickenpox vaccine companies profiled in this report include-

• Bio-Med
• GlaxoSmithKline
• Emcure Pharmaceuticals
• Novo Medi Services
• Sanofi
• Takeda Pharmaceutical
• Changchun BCHT Biotechnology
• Green Cross Holdings
• Merck
• Mitsubishi Chemical Holdings

Chickenpox Vaccine by Segment

The study includes a forecast for the global chickenpox vaccine market by product type, application, end use, and region.

Chickenpox Vaccine Market by Product Type [Analysis by Value from 2019 to 2031]:

• Monovalent Varicella Vaccine
• Combination Varicella Vaccine

Chickenpox Vaccine Market by Application [Analysis by Value from 2019 to 2031]:

• Mumps
• Measles
• Rubella
• Varicella Immunization
• Herpes Zoster
• Immunization
• Chickenpox Vaccination

Chickenpox Vaccine Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Clinics
• Others

Chickenpox Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Chickenpox Vaccine Market

The market for chickenpox vaccines is changing as vaccine technology advances, global vaccination campaigns increase, and awareness of the prevention of chickenpox grows. Recent developments indicate better vaccine formulations, more accessible vaccines, and new public health initiatives aimed at reducing the incidence of chickenpox and its complications.

• United States: In the U.S., there has been progress in varicella vaccines with updated versions that offer improved effectiveness and longer-lasting protection. Better school-based immunization programs and increased vaccine outreach efforts have led to higher vaccination rates and a decrease in outbreaks.
• China: The expansion of access to rural areas and underserved communities has been a key focus for China regarding the distribution of chickenpox vaccines. The government is investing in vaccination programs and public health education to enhance vaccination coverage against chickenpox and control outbreaks.
• Germany: Combination vaccines containing chickenpox and other childhood infections are now being used in Germany. The objective is to minimize the number of shots that children need to receive while increasing adherence. Additionally, Germany is improving its vaccination programs by introducing school mandates and public awareness campaigns.
• India: India's market for chickenpox vaccines is expanding due to an increase in low-cost vaccine availability. Public health campaigns are raising awareness about the significance of immunization, leading to increased uptake, particularly in remote areas where vaccination services are becoming accessible.
• Japan: Japan has made strides in developing better vaccines that provide improved immunity against varicella with fewer side effects. Additionally, Japan aims to include this vaccine in routine immunizations to keep all recipients protected from illness.

Features of the Global Chickenpox Vaccine Market

Market Size Estimates: Chickenpox vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Chickenpox vaccine market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Chickenpox vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the chickenpox vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chickenpox vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the chickenpox vaccine market by product type (monovalent varicella vaccine and combination varicella vaccine), application (mumps, measles, rubella, varicella immunization, herpes zoster, immunization, and chickenpox vaccination), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chickenpox Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Chickenpox Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Chickenpox Vaccine Market by Product Type
  • 3.3.1: Monovalent Varicella Vaccine
  • 3.3.2: Combination Varicella Vaccine
• 3.4: Global Chickenpox Vaccine Market by Application
  • 3.4.1: Mumps
  • 3.4.2: Measles
  • 3.4.3: Rubella
  • 3.4.4: Varicella Immunization
  • 3.4.5: Herpes Zoster
  • 3.4.6: Immunization
  • 3.4.7: Chickenpox Vaccination
• 3.5: Global Chickenpox Vaccine Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Clinics
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Chickenpox Vaccine Market by Region
• 4.2: North American Chickenpox Vaccine Market
  • 4.2.1: North American Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.2.2: North American Market by End Use: Hospitals, Clinics, and Others
• 4.3: European Chickenpox Vaccine Market
  • 4.3.1: European Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.3.2: European Market by End Use: Hospitals, Clinics, and Others
• 4.4: APAC Chickenpox Vaccine Market
  • 4.4.1: APAC Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.4.2: APAC Market by End Use: Hospitals, Clinics, and Others
• 4.5: ROW Chickenpox Vaccine Market
  • 4.5.1: ROW Market by Application: Mumps, Measles, Rubella, Varicella Immunization, Herpes Zoster, Immunization, and Chickenpox Vaccination
  • 4.5.2: ROW Market by End Use: Hospitals, Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Chickenpox Vaccine Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Chickenpox Vaccine Market by Application
  • 6.1.3: Growth Opportunities for the Global Chickenpox Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Chickenpox Vaccine Market by Region
• 6.2: Emerging Trends in the Global Chickenpox Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Chickenpox Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chickenpox Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bio-Med
• 7.2: GlaxoSmithKline
• 7.3: Emcure Pharmaceuticals
• 7.4: Novo Medi Services
• 7.5: Sanofi
• 7.6: Takeda Pharmaceutical
• 7.7: Changchun BCHT Biotechnology
• 7.8: Green Cross Holdings
• 7.9: Merck
• 7.10: Mitsubishi Chemical Holdings